Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
Throughout the last decades, newly developed chemotherapeutic agents and immunotherapies that target signaling pathways have provided patients with better prognoses, improved their quality of life and increased survival rates, thus converting cancer to a stable chronic disease. However, non-anthracy...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI AG
2022-02-01
|
| Cyfres: | Journal of Cardiovascular Development and Disease |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.mdpi.com/2308-3425/9/3/66 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|